Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday. The update about the popular semaglutide injections ...

Good morning, Philly. The exorbitant costs of weight-loss drugs like Wegovy have prompted some insurers to tighten ...

Feb 21 (Reuters) - The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's NOVOb.CO popular weight-loss and diabetes drugs, Wegovy and ...

Wegovy (semaglutide) is a brand-name subcutaneous injection (shot) prescribed for weight loss and to lower the risk of cardiovascular problems in some people. As with other drugs, Wegovy can cause ...

Iowa Attorney General Brenna Bird Friday, March 7 announced a multistate letter urging the Food and Drug Administration to take immediate action to stop the surge in dangerous, counterfeit weight ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for ...

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U ...

Wegovy is a brand-name subcutaneous injection prescribed for weight loss and reduction of cardiovascular risks. Its cost with and without insurance can depend on several factors, such as whether ...

Novo Nordisk, the Danish company behind Wegovy, announced Wednesday that it has lowered its monthly cost by 23%. The new price -- $499 per month -- takes effect immediately. It had been $650 a month.